Component
Agmatine
Study-scoped entity; inspect species, exposure and experimental limitations on each claim.
55 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Agmatine competed at human alpha-2A adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human receptor expression and radioligand competition.
- limitations
- The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An adrenergic receptor is another distinct interaction node.
- primary_references
- Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 292–298
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human receptor expression and radioligand competition. · source_derived_draft · unverified_draft
## agmatine-sulfate-alpha2a-binding An adrenergic receptor is another distinct interaction node. Agmatine competed at human alpha-2A adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study. Model: Human receptor expression and radioligand competition. Limitations: The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine. Evidence access: Primary abstract Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Complete structured claim and evidenceAgmatine competed at human alpha-2B adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human receptor expression and radioligand competition.
- limitations
- The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An adrenergic receptor is another distinct interaction node.
- primary_references
- Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 300–306
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human receptor expression and radioligand competition. · source_derived_draft · unverified_draft
## agmatine-sulfate-alpha2b-binding An adrenergic receptor is another distinct interaction node. Agmatine competed at human alpha-2B adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study. Model: Human receptor expression and radioligand competition. Limitations: The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine. Evidence access: Primary abstract Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Complete structured claim and evidenceAgmatine competed at human alpha-2C adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human receptor expression and radioligand competition.
- limitations
- The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An adrenergic receptor is another distinct interaction node.
- primary_references
- Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 308–314
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human receptor expression and radioligand competition. · source_derived_draft · unverified_draft
## agmatine-sulfate-alpha2c-binding An adrenergic receptor is another distinct interaction node. Agmatine competed at human alpha-2C adrenergic receptors expressed in transfected cells in the 1995 receptor-panel study. Model: Human receptor expression and radioligand competition. Limitations: The study establishes binding in its assay, not that agmatine reproduces every action of clonidine or norepinephrine. Evidence access: Primary abstract Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Complete structured claim and evidenceAgmatine promoted an antizyme-mRNA frameshift producing full-length antizyme; anti-antizyme antibody or antizyme inhibitor suppressed associated inhibitory activity.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell and translation assays; exact construct and cell species not resolved in accessed abstract.
- limitations
- This is not assigned to a human isoform without checking the complete preparation.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- It can influence production of a regulator of polyamine metabolism.
- primary_references
- Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9624108/ · DOI 10.1074/jbc.273.25.15313
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 340–346
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell and translation assays; exact construct and cell species not resolved in accessed abstract. · source_derived_draft · unverified_draft
## agmatine-sulfate-antizyme-frameshift It can influence production of a regulator of polyamine metabolism. Agmatine promoted an antizyme-mRNA frameshift producing full-length antizyme; anti-antizyme antibody or antizyme inhibitor suppressed associated inhibitory activity. Model: Cell and translation assays; exact construct and cell species not resolved in accessed abstract. Limitations: This is not assigned to a human isoform without checking the complete preparation. Evidence access: Primary abstract Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9624108/ · DOI 10.1074/jbc.273.25.15313
Complete structured claim and evidenceAgmatine and endogenous bovine hypothalamic clonidine-displacing material had different affinity rankings across the tested receptor panel.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human and bovine receptor preparations with purified compound and endogenous extract.
- limitations
- This qualifies the identity of the extract; it does not negate agmatine binding.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An extract containing an active compound can have additional active constituents.
- primary_references
- Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 316–322
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human and bovine receptor preparations with purified compound and endogenous extract. · source_derived_draft · unverified_draft
## agmatine-sulfate-cds-specificity An extract containing an active compound can have additional active constituents. Agmatine and endogenous bovine hypothalamic clonidine-displacing material had different affinity rankings across the tested receptor panel. Model: Human and bovine receptor preparations with purified compound and endogenous extract. Limitations: This qualifies the identity of the extract; it does not negate agmatine binding. Evidence access: Primary abstract Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Complete structured claim and evidenceAgmatine induced cytosolic calcium transients in bovine pulmonary artery endothelial cells; repeated exposure downregulated the response.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cultured bovine pulmonary artery endothelial cells.
- limitations
- Dose was not available in the accessed abstract; no dietary calcium-depletion claim is made.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The compound can change the activating signal upstream of an enzyme.
- primary_references
- Agmatine activation of nitric oxide synthase in endothelial cells. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9010916/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 244–250
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cultured bovine pulmonary artery endothelial cells. · source_derived_draft · unverified_draft
## agmatine-sulfate-endothelial-calcium The compound can change the activating signal upstream of an enzyme. Agmatine induced cytosolic calcium transients in bovine pulmonary artery endothelial cells; repeated exposure downregulated the response. Model: Cultured bovine pulmonary artery endothelial cells. Limitations: Dose was not available in the accessed abstract; no dietary calcium-depletion claim is made. Evidence access: Primary abstract Agmatine activation of nitric oxide synthase in endothelial cells. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9010916/
Complete structured claim and evidenceAgmatine increased nitrite production about threefold in bovine endothelial cells; idazoxan inhibited the effect whereas yohimbine did not.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Bovine endothelial culture; pharmacological antagonist comparison.
- limitations
- The imidazoline-associated mechanism is pharmacologically inferred; a specific receptor gene was not established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An intact-cell signaling effect can differ from direct enzyme inhibition.
- primary_references
- Agmatine activation of nitric oxide synthase in endothelial cells. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9010916/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 252–258
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Bovine endothelial culture; pharmacological antagonist comparison. · source_derived_draft · unverified_draft
## agmatine-sulfate-endothelial-no An intact-cell signaling effect can differ from direct enzyme inhibition. Agmatine increased nitrite production about threefold in bovine endothelial cells; idazoxan inhibited the effect whereas yohimbine did not. Model: Bovine endothelial culture; pharmacological antagonist comparison. Limitations: The imidazoline-associated mechanism is pharmacologically inferred; a specific receptor gene was not established. Evidence access: Primary abstract Agmatine activation of nitric oxide synthase in endothelial cells. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9010916/
Complete structured claim and evidenceAgmatine bound human platelet I1 sites with high- and low-affinity components and preferential affinity for the high-affinity I1 component over tested alpha-2 subtypes.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human platelet membrane radioligand competition.
- limitations
- Binding alone does not establish agonist efficacy, receptor sequence or clinical blood-pressure effects.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A pharmacological binding site is recorded without inventing its molecular identity.
- primary_references
- Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 284–290
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human platelet membrane radioligand competition. · source_derived_draft · unverified_draft
## agmatine-sulfate-human-i1-binding A pharmacological binding site is recorded without inventing its molecular identity. Agmatine bound human platelet I1 sites with high- and low-affinity components and preferential affinity for the high-affinity I1 component over tested alpha-2 subtypes. Model: Human platelet membrane radioligand competition. Limitations: Binding alone does not establish agonist efficacy, receptor sequence or clinical blood-pressure effects. Evidence access: Primary abstract Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7853171/
Complete structured claim and evidenceAt conditions inhibiting swelling, agmatine still enhanced cytochrome-c and Smac/DIABLO release while preventing AIF release.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Same isolated rat mitochondrial study with inhibitor probes.
- limitations
- Outer-membrane permeabilization was proposed; it is not a demonstrated beneficial effect of supplementation.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Less swelling did not mean that every cell-death-related endpoint was prevented.
- primary_references
- Involvement of the biogenic active amine agmatine in mitochondrial membrane permeabilization and release of pro-apoptotic factors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/31654209/ · DOI 10.1007/s00726-019-02791-6
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 396–402
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Same isolated rat mitochondrial study with inhibitor probes. · source_derived_draft · unverified_draft
## agmatine-sulfate-mitochondrial-release Less swelling did not mean that every cell-death-related endpoint was prevented. At conditions inhibiting swelling, agmatine still enhanced cytochrome-c and Smac/DIABLO release while preventing AIF release. Model: Same isolated rat mitochondrial study with inhibitor probes. Limitations: Outer-membrane permeabilization was proposed; it is not a demonstrated beneficial effect of supplementation. Evidence access: Primary abstract Involvement of the biogenic active amine agmatine in mitochondrial membrane permeabilization and release of pro-apoptotic factors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/31654209/ · DOI 10.1007/s00726-019-02791-6
Complete structured claim and evidenceAgmatine induced permeability transition at lower tested concentrations but inhibited calcium/phosphate-associated swelling at higher concentrations in isolated rat liver mitochondria.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Isolated rat liver mitochondria; swelling and protein-release assays.
- limitations
- Numerical concentration ranges are not provided in the accessed abstract; no human protective threshold is inferred.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A compound can change direction across concentrations and assay endpoints.
- primary_references
- Involvement of the biogenic active amine agmatine in mitochondrial membrane permeabilization and release of pro-apoptotic factors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/31654209/ · DOI 10.1007/s00726-019-02791-6
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 388–394
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Isolated rat liver mitochondria; swelling and protein-release assays. · source_derived_draft · unverified_draft
## agmatine-sulfate-mitochondrial-state A compound can change direction across concentrations and assay endpoints. Agmatine induced permeability transition at lower tested concentrations but inhibited calcium/phosphate-associated swelling at higher concentrations in isolated rat liver mitochondria. Model: Isolated rat liver mitochondria; swelling and protein-release assays. Limitations: Numerical concentration ranges are not provided in the accessed abstract; no human protective threshold is inferred. Evidence access: Primary abstract Involvement of the biogenic active amine agmatine in mitochondrial membrane permeabilization and release of pro-apoptotic factors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/31654209/ · DOI 10.1007/s00726-019-02791-6
Complete structured claim and evidenceAgmatine at 1 mM reduced DMPP-induced chick retinal depolarization by approximately 70% without preventing neuronal bungarotoxin binding.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Intact chick retina and retinal-homogenate binding assays.
- limitations
- Millimolar exposure; exact human receptor subunits or oral effects are not established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Nicotinic function was blocked without competing at that toxin-binding site.
- primary_references
- Agmatine acts as an antagonist of neuronal nicotinic receptors. · 1990 · https://pubmed.ncbi.nlm.nih.gov/2331571/ · DOI 10.1111/j.1476-5381.1990.tb14680.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 324–330
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Intact chick retina and retinal-homogenate binding assays. · source_derived_draft · unverified_draft
## agmatine-sulfate-nicotinic-chick Nicotinic function was blocked without competing at that toxin-binding site. Agmatine at 1 mM reduced DMPP-induced chick retinal depolarization by approximately 70% without preventing neuronal bungarotoxin binding. Model: Intact chick retina and retinal-homogenate binding assays. Limitations: Millimolar exposure; exact human receptor subunits or oral effects are not established. Evidence access: Primary abstract Agmatine acts as an antagonist of neuronal nicotinic receptors. · 1990 · https://pubmed.ncbi.nlm.nih.gov/2331571/ · DOI 10.1111/j.1476-5381.1990.tb14680.x
Complete structured claim and evidenceAgmatine at 10 micromolar substantially blocked DMPP depolarization and synaptic transmission in rat superior cervical ganglion.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat isolated ganglion experiments.
- limitations
- Different tissue sensitivities are not interchangeable dose estimates.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A second tissue showed nicotinic inhibition at a different exposure.
- primary_references
- Agmatine acts as an antagonist of neuronal nicotinic receptors. · 1990 · https://pubmed.ncbi.nlm.nih.gov/2331571/ · DOI 10.1111/j.1476-5381.1990.tb14680.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 332–338
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat isolated ganglion experiments. · source_derived_draft · unverified_draft
## agmatine-sulfate-nicotinic-rat A second tissue showed nicotinic inhibition at a different exposure. Agmatine at 10 micromolar substantially blocked DMPP depolarization and synaptic transmission in rat superior cervical ganglion. Model: Rat isolated ganglion experiments. Limitations: Different tissue sensitivities are not interchangeable dose estimates. Evidence access: Primary abstract Agmatine acts as an antagonist of neuronal nicotinic receptors. · 1990 · https://pubmed.ncbi.nlm.nih.gov/2331571/ · DOI 10.1111/j.1476-5381.1990.tb14680.x
Complete structured claim and evidenceExtracellular agmatine blocked NMDA currents in rat hippocampal neurons in a voltage- and concentration-dependent manner; estimated pore-site Kd was 952 micromolar at 0 mV.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cultured rat hippocampal neurons; whole-cell patch clamp.
- limitations
- The inferred pore site is not a solved binding structure or measured oral human brain exposure.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Its glutamate-receptor effect depends on electrical conditions and concentration.
- primary_references
- Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 260–266
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cultured rat hippocampal neurons; whole-cell patch clamp. · source_derived_draft · unverified_draft
## agmatine-sulfate-nmda-block Its glutamate-receptor effect depends on electrical conditions and concentration. Extracellular agmatine blocked NMDA currents in rat hippocampal neurons in a voltage- and concentration-dependent manner; estimated pore-site Kd was 952 micromolar at 0 mV. Model: Cultured rat hippocampal neurons; whole-cell patch clamp. Limitations: The inferred pore site is not a solved binding structure or measured oral human brain exposure. Evidence access: Primary abstract Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Complete structured claim and evidenceAgmatine competitively inhibited the brain-derived NOS I preparation with approximate Ki 660 micromolar and was not an NO precursor.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract.
- limitations
- Isolated-preparation potency does not quantify inhibition after an oral sulfate dose.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An arginine-related compound can inhibit the enzyme rather than supply its product.
- primary_references
- Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 220–226
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract. · source_derived_draft · unverified_draft
## agmatine-sulfate-nos1-inhibition An arginine-related compound can inhibit the enzyme rather than supply its product. Agmatine competitively inhibited the brain-derived NOS I preparation with approximate Ki 660 micromolar and was not an NO precursor. Model: NOS activity measured by nitrite or citrulline production; species not specified in accessed abstract. Limitations: Isolated-preparation potency does not quantify inhibition after an oral sulfate dose. Evidence access: Primary abstract Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Complete structured claim and evidenceAgmatine competitively inhibited macrophage-derived NOS II with approximate Ki 220 micromolar.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Macrophage NOS preparation; enzymatic activity assay.
- limitations
- This is not a universal inflammatory-cell response or a human concentration target.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- NOS isoforms showed different assay sensitivities.
- primary_references
- Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 228–234
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Macrophage NOS preparation; enzymatic activity assay. · source_derived_draft · unverified_draft
## agmatine-sulfate-nos2-inhibition NOS isoforms showed different assay sensitivities. Agmatine competitively inhibited macrophage-derived NOS II with approximate Ki 220 micromolar. Model: Macrophage NOS preparation; enzymatic activity assay. Limitations: This is not a universal inflammatory-cell response or a human concentration target. Evidence access: Primary abstract Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Complete structured claim and evidenceAgmatine competitively inhibited endothelial-derived NOS III only at a much higher approximate Ki of 7.5 mM in the isoform comparison.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Endothelial NOS enzyme preparation.
- limitations
- This enzyme result is distinct from upstream signaling in intact endothelial cells.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Direct inhibition of one isoform can require a very different concentration.
- primary_references
- Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 236–242
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Endothelial NOS enzyme preparation. · source_derived_draft · unverified_draft
## agmatine-sulfate-nos3-inhibition Direct inhibition of one isoform can require a very different concentration. Agmatine competitively inhibited endothelial-derived NOS III only at a much higher approximate Ki of 7.5 mM in the isoform comparison. Model: Endothelial NOS enzyme preparation. Limitations: This enzyme result is distinct from upstream signaling in intact endothelial cells. Evidence access: Primary abstract Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. · 1996 · https://pubmed.ncbi.nlm.nih.gov/8645212/ · DOI 10.1042/bj3160247
Complete structured claim and evidenceAbout 50% of taken-up radiolabeled agmatine was recovered as 4-guanidinobutyrate in the rat hepatocyte experiment.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat hepatocyte culture; HPLC and mass spectrometry.
- limitations
- The percentage is specific to this experiment and is not a human whole-body metabolic fraction.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Oxidation can redirect the molecule away from the polyamine route.
- primary_references
- Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 92–98
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat hepatocyte culture; HPLC and mass spectrometry. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-gba Oxidation can redirect the molecule away from the polyamine route. About 50% of taken-up radiolabeled agmatine was recovered as 4-guanidinobutyrate in the rat hepatocyte experiment. Model: Rat hepatocyte culture; HPLC and mass spectrometry. Limitations: The percentage is specific to this experiment and is not a human whole-body metabolic fraction. Evidence access: Primary abstract Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Complete structured claim and evidenceAgmatine reduced ODC activity before antizyme rose; proteasome inhibition did not prevent the ODC effect in rat pulmonary endothelial cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat pulmonary artery endothelial culture; timing and proteasome interventions.
- limitations
- The mechanism was not resolved; this is a limit on generalizing the antizyme-only model.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Antizyme induction did not explain every observed effect in this preparation.
- primary_references
- Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11160620/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 356–362
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat pulmonary artery endothelial culture; timing and proteasome interventions. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-odc-timing Antizyme induction did not explain every observed effect in this preparation. Agmatine reduced ODC activity before antizyme rose; proteasome inhibition did not prevent the ODC effect in rat pulmonary endothelial cells. Model: Rat pulmonary artery endothelial culture; timing and proteasome interventions. Limitations: The mechanism was not resolved; this is a limit on generalizing the antizyme-only model. Evidence access: Primary abstract Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11160620/
Complete structured claim and evidenceAgmatine present in culture medium competitively inhibited radiolabeled polyamine uptake, increasing apparent Km.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat pulmonary endothelial transport kinetics.
- limitations
- No universal human polyamine depletion magnitude or clinical supplement interaction is established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Immediate transport competition can coexist with slower regulation of protein expression.
- primary_references
- Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11160620/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 364–370
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat pulmonary endothelial transport kinetics. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-polyamine-competition Immediate transport competition can coexist with slower regulation of protein expression. Agmatine present in culture medium competitively inhibited radiolabeled polyamine uptake, increasing apparent Km. Model: Rat pulmonary endothelial transport kinetics. Limitations: No universal human polyamine depletion magnitude or clinical supplement interaction is established. Evidence access: Primary abstract Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11160620/
Complete structured claim and evidenceAbout 10% of taken-up agmatine label entered the polyamine pool in rat hepatocyte cultures.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Primary rat hepatocytes with radiotracer.
- limitations
- The abstract reports a polyamine pool, not a putrescine-only percentage or purified human AGMAT reaction.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Agmatine can feed polyamine metabolism in a defined preparation.
- primary_references
- Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 100–106
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary rat hepatocytes with radiotracer. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-polyamine-production Agmatine can feed polyamine metabolism in a defined preparation. About 10% of taken-up agmatine label entered the polyamine pool in rat hepatocyte cultures. Model: Primary rat hepatocytes with radiotracer. Limitations: The abstract reports a polyamine pool, not a putrescine-only percentage or purified human AGMAT reaction. Evidence access: Primary abstract Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Complete structured claim and evidence
What acts on it
Purified recombinant human AGMAT variants R105 and G105 showed no detected agmatine hydrolysis at 10 mM substrate in the 2022 assay.
Experimental context and source evidence
- evidence_access
- Primary full text; Figures 1 and 2
- experimental_model
- Human proteins expressed in E. coli; urea assay, detection limit about 0.02 nmol/s/mg.
- limitations
- This assay result revises the proposed substrate assignment; it does not prove that humans cannot metabolize agmatine by other routes.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A gene name does not guarantee the biochemical reaction usually drawn beside it.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 116–122
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human proteins expressed in E. coli; urea assay, detection limit about 0.02 nmol/s/mg. · source_derived_draft · unverified_draft
## agmatine-sulfate-agmat-reannotation A gene name does not guarantee the biochemical reaction usually drawn beside it. Purified recombinant human AGMAT variants R105 and G105 showed no detected agmatine hydrolysis at 10 mM substrate in the 2022 assay. Model: Human proteins expressed in E. coli; urea assay, detection limit about 0.02 nmol/s/mg. Limitations: This assay result revises the proposed substrate assignment; it does not prove that humans cannot metabolize agmatine by other routes. Evidence access: Primary full text; Figures 1 and 2 Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceHuman MATE1 expression increased saturable agmatine accumulation, with Km 240 ± 31 micromolar.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MATE1 in HEK293 cells.
- limitations
- Accumulation direction in the assay is not identical to net secretion across an intact kidney.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A transporter associated with renal secretion recognizes agmatine.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
- transport_effect
- raises Expression increased saturable agmatine accumulation in the cell.
- transport_pool
- the expressing cell Expression increased saturable agmatine accumulation in the cell.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 36–42
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MATE1 in HEK293 cells. · source_derived_draft · unverified_draft
## agmatine-sulfate-mate1 A transporter associated with renal secretion recognizes agmatine. Human MATE1 expression increased saturable agmatine accumulation, with Km 240 ± 31 micromolar. Model: Human MATE1 in HEK293 cells. Limitations: Accumulation direction in the assay is not identical to net secretion across an intact kidney. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceHuman OCT1 expression increased concentration-dependent agmatine transport in HEK293 cells, with Km 18.73 ± 4.86 mM.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human transporter expressed in HEK293 cells; radiolabeled agmatine.
- limitations
- An in vitro Km is not a target blood concentration or oral bioavailability estimate.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A transporter can admit the molecule, but its affinity matters.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
- transport_effect
- raises Expression increased concentration-dependent agmatine transport into HEK293 cells.
- transport_pool
- the expressing cell Expression increased concentration-dependent agmatine transport into HEK293 cells.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 20–26
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transporter expressed in HEK293 cells; radiolabeled agmatine. · source_derived_draft · unverified_draft
## agmatine-sulfate-oct1 A transporter can admit the molecule, but its affinity matters. Human OCT1 expression increased concentration-dependent agmatine transport in HEK293 cells, with Km 18.73 ± 4.86 mM. Model: Human transporter expressed in HEK293 cells; radiolabeled agmatine. Limitations: An in vitro Km is not a target blood concentration or oral bioavailability estimate. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceHuman OCT2 mediated pH- and concentration-dependent agmatine transport, with Km 1.84 ± 0.38 mM.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Matched human transporter expression systems.
- limitations
- Protein expression and assay conditions affect comparison with actual kidney clearance.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Another organic-cation transporter handles agmatine more avidly in this assay.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
- transport_effect
- raises pH- and concentration-dependent agmatine transport into the expressing cell.
- transport_pool
- the expressing cell pH- and concentration-dependent agmatine transport into the expressing cell.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 28–34
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Matched human transporter expression systems. · source_derived_draft · unverified_draft
## agmatine-sulfate-oct2 Another organic-cation transporter handles agmatine more avidly in this assay. Human OCT2 mediated pH- and concentration-dependent agmatine transport, with Km 1.84 ± 0.38 mM. Model: Matched human transporter expression systems. Limitations: Protein expression and assay conditions affect comparison with actual kidney clearance. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceTransformed mouse NIH/3T3 cells took up agmatine through an energy- and membrane-potential-dependent saturable system with apparent Km 2.5 micromolar.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse transformed fibroblast transport experiments.
- limitations
- The molecular transporter gene was not identified; this system is not automatically OCT2 or MATE1.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Different cells can have much higher-affinity uptake than a single recombinant transporter.
- primary_references
- Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
- transport_effect
- raises Cells took up agmatine through an energy- and membrane-potential-dependent saturable system.
- transport_pool
- the expressing cell Cells took up agmatine through an energy- and membrane-potential-dependent saturable system.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 60–66
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse transformed fibroblast transport experiments. · source_derived_draft · unverified_draft
## agmatine-sulfate-polyamine-carrier Different cells can have much higher-affinity uptake than a single recombinant transporter. Transformed mouse NIH/3T3 cells took up agmatine through an energy- and membrane-potential-dependent saturable system with apparent Km 2.5 micromolar. Model: Mouse transformed fibroblast transport experiments. Limitations: The molecular transporter gene was not identified; this system is not automatically OCT2 or MATE1. Evidence access: Primary abstract Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
Complete structured claim and evidenceRecombinant rat-brain agmatinase-like protein catalyzed agmatine hydrolysis; its central 210-residue construct retained activity with reduced kcat.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat ALP recombinant constructs and enzyme kinetics.
- limitations
- ALP is not interchangeable with the AGMAT gene product; no human oral exposure outcome is shown.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A distinct protein preparation can perform the reaction missing from purified human AGMAT.
- primary_references
- Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32531922/ · DOI 10.3390/ijms21114132
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 148–154
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat ALP recombinant constructs and enzyme kinetics. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-alp-reaction A distinct protein preparation can perform the reaction missing from purified human AGMAT. Recombinant rat-brain agmatinase-like protein catalyzed agmatine hydrolysis; its central 210-residue construct retained activity with reduced kcat. Model: Rat ALP recombinant constructs and enzyme kinetics. Limitations: ALP is not interchangeable with the AGMAT gene product; no human oral exposure outcome is shown. Evidence access: Primary abstract Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32531922/ · DOI 10.3390/ijms21114132
Complete structured claim and evidenceRat hepatocytes exhibited high-affinity agmatine uptake with Km 0.03 mM; the system also transported putrescine but not arginine, spermidine or spermine.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Primary rat hepatocyte cultures and radiolabeled substrate.
- limitations
- Different selectivity from other polyamine uptake systems is a context difference, not a universal contradiction.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Competition depends on which cell and transport route is being studied.
- primary_references
- Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
- transport_effect
- raises Hepatocytes showed high-affinity agmatine uptake with a Km of 0.03 mM.
- transport_pool
- the hepatocyte interior Hepatocytes showed high-affinity agmatine uptake with a Km of 0.03 mM.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 76–82
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary rat hepatocyte cultures and radiolabeled substrate. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-liver-uptake Competition depends on which cell and transport route is being studied. Rat hepatocytes exhibited high-affinity agmatine uptake with Km 0.03 mM; the system also transported putrescine but not arginine, spermidine or spermine. Model: Primary rat hepatocyte cultures and radiolabeled substrate. Limitations: Different selectivity from other polyamine uptake systems is a context difference, not a universal contradiction. Evidence access: Primary abstract Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Complete structured claim and evidenceArginine-derived tracer also appeared in agmatine, without suppression by the arginase inhibitor.
Experimental context and source evidence
- evidence_access
- Full-text results, Figures 2 and 6, Europe PMC PMC5075284; primary abstract.
- experimental_model
- Primary human activated T cells; isotope tracing and functional assays.
- limitations
- The responsible enzyme was not established here; no universal human arginine-decarboxylase assignment.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- A separate metabolic branch remained detectable.
- primary_references
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27745970/ · DOI 10.1016/j.cell.2016.09.031
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 230–236
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Primary human activated T cells; isotope tracing and functional assays. · source_derived_draft · unverified_draft
## arg-tcell-agmatine A separate metabolic branch remained detectable. Arginine-derived tracer also appeared in agmatine, without suppression by the arginase inhibitor. Model: Primary human activated T cells; isotope tracing and functional assays. Limitations: The responsible enzyme was not established here; no universal human arginine-decarboxylase assignment. Evidence access: Full-text results, Figures 2 and 6, Europe PMC PMC5075284; primary abstract. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27745970/ · DOI 10.1016/j.cell.2016.09.031
Complete structured claim and evidence
Where it participates (unsigned role)
Both purified human AGMAT variants hydrolyzed guanidinobutyrate, supporting a guanidino-acid hydrolase function.
Experimental context and source evidence
- evidence_access
- Primary full text; Figures 2 and 3
- experimental_model
- Purified recombinant human R105 and G105 variants.
- limitations
- Measured Km values for the tested guanidino acids exceeded 50 mM; physiological substrate flux remains unresolved.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The same protein was active when supplied a different substrate.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 124–130
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified recombinant human R105 and G105 variants. · source_derived_draft · unverified_draft
## agmatine-sulfate-agmat-gba The same protein was active when supplied a different substrate. Both purified human AGMAT variants hydrolyzed guanidinobutyrate, supporting a guanidino-acid hydrolase function. Model: Purified recombinant human R105 and G105 variants. Limitations: Measured Km values for the tested guanidino acids exceeded 50 mM; physiological substrate flux remains unresolved. Evidence access: Primary full text; Figures 2 and 3 Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceExpressing human AGMAT R105 in medium supplemented with 0.5 mM manganese increased its subsequent taurocyamine-hydrolysis activity approximately fourfold.
Experimental context and source evidence
- evidence_access
- Primary full text; Figure 3B
- experimental_model
- Recombinant human enzyme produced in bacterial expression culture.
- limitations
- This is not evidence that manganese supplements activate human agmatine breakdown; agmatine was not an accepted substrate.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Metal handling during enzyme production affects measured activity.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 140–146
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human enzyme produced in bacterial expression culture. · source_derived_draft · unverified_draft
## agmatine-sulfate-agmat-manganese Metal handling during enzyme production affects measured activity. Expressing human AGMAT R105 in medium supplemented with 0.5 mM manganese increased its subsequent taurocyamine-hydrolysis activity approximately fourfold. Model: Recombinant human enzyme produced in bacterial expression culture. Limitations: This is not evidence that manganese supplements activate human agmatine breakdown; agmatine was not an accepted substrate. Evidence access: Primary full text; Figure 3B Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceHuman AGMAT R105 hydrolyzed taurocyamine more efficiently than guanidinobutyrate in the tested concentration range; R105 and G105 differed in substrate preferences.
Experimental context and source evidence
- evidence_access
- Primary full text; Figures 2 and 3
- experimental_model
- Purified human variants; 10 mM substrate comparison and concentration series.
- limitations
- This does not establish a clinically meaningful taurine deficit or a supplementation response.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A variant can alter which related metabolic pool is processed.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 132–138
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human variants; 10 mM substrate comparison and concentration series. · source_derived_draft · unverified_draft
## agmatine-sulfate-agmat-taurocyamine A variant can alter which related metabolic pool is processed. Human AGMAT R105 hydrolyzed taurocyamine more efficiently than guanidinobutyrate in the tested concentration range; R105 and G105 differed in substrate preferences. Model: Purified human variants; 10 mM substrate comparison and concentration series. Limitations: This does not establish a clinically meaningful taurine deficit or a supplementation response. Evidence access: Primary full text; Figures 2 and 3 Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceAdding diamine oxidase or inhibiting aldehyde dehydrogenase increased agmatine-associated suppression of inducible NO generation; aldehyde removal or trapping attenuated it.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cytokine-stimulated cell preparations; enzyme additions, inhibitors and aldehyde trapping.
- limitations
- The accessed abstract does not fully specify each cell species, dose or enzyme isoform. It supports aldehyde involvement rather than a direct binding target.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- How a compound is metabolized can change its signaling effect.
- primary_references
- Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11473357/ · DOI 10.1002/jcp.1119
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 108–114
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cytokine-stimulated cell preparations; enzyme additions, inhibitors and aldehyde trapping. · source_derived_draft · unverified_draft
## agmatine-sulfate-aldehyde-no How a compound is metabolized can change its signaling effect. Adding diamine oxidase or inhibiting aldehyde dehydrogenase increased agmatine-associated suppression of inducible NO generation; aldehyde removal or trapping attenuated it. Model: Cytokine-stimulated cell preparations; enzyme additions, inhibitors and aldehyde trapping. Limitations: The accessed abstract does not fully specify each cell species, dose or enzyme isoform. It supports aldehyde involvement rather than a direct binding target. Evidence access: Primary abstract Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11473357/ · DOI 10.1002/jcp.1119
Complete structured claim and evidenceL-arginine at 600 mg/kg intraperitoneally attenuated agmatine-associated antinociception in the mouse acetic-acid test.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse chemical-pain assays; high-dose injected arginine.
- limitations
- This does not prove that normal dietary arginine negates an oral agmatine supplement or identify one exclusive target.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A precursor-related nutrient changed the response in a pharmacological animal experiment.
- primary_references
- Mechanisms involved in the antinociception caused by agmatine in mice. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15857629/ · DOI 10.1016/j.neuropharm.2005.01.012
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 428–434
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse chemical-pain assays; high-dose injected arginine. · source_derived_draft · unverified_draft
## agmatine-sulfate-arginine-pain-interaction A precursor-related nutrient changed the response in a pharmacological animal experiment. L-arginine at 600 mg/kg intraperitoneally attenuated agmatine-associated antinociception in the mouse acetic-acid test. Model: Mouse chemical-pain assays; high-dose injected arginine. Limitations: This does not prove that normal dietary arginine negates an oral agmatine supplement or identify one exclusive target. Evidence access: Primary abstract Mechanisms involved in the antinociception caused by agmatine in mice. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15857629/ · DOI 10.1016/j.neuropharm.2005.01.012
Complete structured claim and evidenceHuman ODC paralogue/AZIN2 had no intrinsic arginine-decarboxylase activity in the reported experiments.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human protein biochemical and cell studies.
- limitations
- This rejects that assignment, not every possible source of mammalian agmatine.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Do not assign a human agmatine-synthesis reaction to AZIN2 just because older names suggest it.
- primary_references
- Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. · 2008 · https://pubmed.ncbi.nlm.nih.gov/17900240/ · DOI 10.1042/BJ20071004
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 172–178
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human protein biochemical and cell studies. · source_derived_draft · unverified_draft
## agmatine-sulfate-azin2-identity Do not assign a human agmatine-synthesis reaction to AZIN2 just because older names suggest it. Human ODC paralogue/AZIN2 had no intrinsic arginine-decarboxylase activity in the reported experiments. Model: Human protein biochemical and cell studies. Limitations: This rejects that assignment, not every possible source of mammalian agmatine. Evidence access: Primary abstract Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. · 2008 · https://pubmed.ncbi.nlm.nih.gov/17900240/ · DOI 10.1042/BJ20071004
Complete structured claim and evidenceHuman AZIN2 bound antizymes and counteracted AZ1-dependent suppression and degradation of ODC.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Yeast two-hybrid, binding, ODC activity and degradation assays.
- limitations
- Binding and functional inhibition were studied; no oral supplement response is inferred.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A regulatory protein can change polyamine supply without synthesizing agmatine itself.
- primary_references
- Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. · 2008 · https://pubmed.ncbi.nlm.nih.gov/17900240/ · DOI 10.1042/BJ20071004
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 180–186
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Yeast two-hybrid, binding, ODC activity and degradation assays. · source_derived_draft · unverified_draft
## agmatine-sulfate-azin2-regulation A regulatory protein can change polyamine supply without synthesizing agmatine itself. Human AZIN2 bound antizymes and counteracted AZ1-dependent suppression and degradation of ODC. Model: Yeast two-hybrid, binding, ODC activity and degradation assays. Limitations: Binding and functional inhibition were studied; no oral supplement response is inferred. Evidence access: Primary abstract Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. · 2008 · https://pubmed.ncbi.nlm.nih.gov/17900240/ · DOI 10.1042/BJ20071004
Complete structured claim and evidenceMetformin no longer extended C. elegans lifespan when worms ate E. coli lacking both agmatine-production genes adiA and speA.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text; Figure 4I
- experimental_model
- Worm lifespan with defined E. coli deletion mutants.
- limitations
- No human lifespan extension or agmatine-sulfate/metformin combination efficacy is established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A drug response depended on the microbes in a specific experimental system.
- primary_references
- Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 412–418
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Worm lifespan with defined E. coli deletion mutants. · source_derived_draft · unverified_draft
## agmatine-sulfate-bacterial-metformin A drug response depended on the microbes in a specific experimental system. Metformin no longer extended C. elegans lifespan when worms ate E. coli lacking both agmatine-production genes adiA and speA. Model: Worm lifespan with defined E. coli deletion mutants. Limitations: No human lifespan extension or agmatine-sulfate/metformin combination efficacy is established. Evidence access: Primary full text; Figure 4I Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
Complete structured claim and evidenceDeleting E. coli speB increased the worm acs-2 reporter response; deleting additional agmatine-production genes abolished that increase.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text; Figure 4 and Figure S5
- experimental_model
- E. coli OP50 mutants feeding C. elegans.
- limitations
- This is a worm–bacterium experiment, not human gene manipulation or demonstrated clinical synergy.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Bacterial production and disposal influence a host metabolic signal.
- primary_references
- Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 404–410
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · E. coli OP50 mutants feeding C. elegans. · source_derived_draft · unverified_draft
## agmatine-sulfate-bacterial-speb Bacterial production and disposal influence a host metabolic signal. Deleting E. coli speB increased the worm acs-2 reporter response; deleting additional agmatine-production genes abolished that increase. Model: E. coli OP50 mutants feeding C. elegans. Limitations: This is a worm–bacterium experiment, not human gene manipulation or demonstrated clinical synergy. Evidence access: Primary full text; Figure 4 and Figure S5 Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
Complete structured claim and evidencePutrescine and idazoxan inhibited rat brain mitochondrial agmatine uptake despite being ineffective in the compared liver mitochondrial preparation.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Isolated rat brain versus liver mitochondria.
- limitations
- A pharmacological pattern does not establish a particular I2 receptor protein as the transporter.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Compartment and organ identity change which interactions occur.
- primary_references
- Agmatine transport in brain mitochondria: a different mechanism from that in liver mitochondria. · 2010 · https://pubmed.ncbi.nlm.nih.gov/19997762/ · DOI 10.1007/s00726-009-0401-1
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 380–386
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Isolated rat brain versus liver mitochondria. · source_derived_draft · unverified_draft
## agmatine-sulfate-brain-mito-transport Compartment and organ identity change which interactions occur. Putrescine and idazoxan inhibited rat brain mitochondrial agmatine uptake despite being ineffective in the compared liver mitochondrial preparation. Model: Isolated rat brain versus liver mitochondria. Limitations: A pharmacological pattern does not establish a particular I2 receptor protein as the transporter. Evidence access: Primary abstract Agmatine transport in brain mitochondria: a different mechanism from that in liver mitochondria. · 2010 · https://pubmed.ncbi.nlm.nih.gov/19997762/ · DOI 10.1007/s00726-009-0401-1
Complete structured claim and evidenceAgmatine uptake was abrogated in a polyamine-transport-deficient human carcinoma cell line.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human transport-deficient carcinoma cells compared with transport-capable cells.
- limitations
- Not an inherited human deficiency syndrome or proof of nutrient depletion.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- An extracellular supply cannot compensate for absent entry in this model.
- primary_references
- Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 68–74
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transport-deficient carcinoma cells compared with transport-capable cells. · source_derived_draft · unverified_draft
## agmatine-sulfate-carrier-loss An extracellular supply cannot compensate for absent entry in this model. Agmatine uptake was abrogated in a polyamine-transport-deficient human carcinoma cell line. Model: Human transport-deficient carcinoma cells compared with transport-capable cells. Limitations: Not an inherited human deficiency syndrome or proof of nutrient depletion. Evidence access: Primary abstract Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
Complete structured claim and evidenceFour purified human creatine-kinase isoforms phosphorylated creatine but not taurocyamine, guanidinobutyrate or guanidinopropionate at 10 mM test substrate.
Experimental context and source evidence
- evidence_access
- Primary full text; Figure 4A
- experimental_model
- Human recombinant kinases; radiolabeled ATP and TLC; annelid taurocyamine kinase positive control.
- limitations
- The experimental result does not exclude every reaction at other conditions, but does not support replacing creatine.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Related guanidino compounds are not automatically interchangeable energy buffers.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 212–218
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human recombinant kinases; radiolabeled ATP and TLC; annelid taurocyamine kinase positive control. · source_derived_draft · unverified_draft
## agmatine-sulfate-creatine-specificity Related guanidino compounds are not automatically interchangeable energy buffers. Four purified human creatine-kinase isoforms phosphorylated creatine but not taurocyamine, guanidinobutyrate or guanidinopropionate at 10 mM test substrate. Model: Human recombinant kinases; radiolabeled ATP and TLC; annelid taurocyamine kinase positive control. Limitations: The experimental result does not exclude every reaction at other conditions, but does not support replacing creatine. Evidence access: Primary full text; Figure 4A Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceDifluoromethylornithine-induced polyamine depletion increased agmatine uptake in cultured rat hepatocytes.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Pharmacological ODC inhibition in rat hepatocyte culture.
- limitations
- This is experimentally induced cellular polyamine depletion, not ordinary dietary agmatine deficiency.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A depleted downstream pool can change entry of another compound.
- primary_references
- Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 84–90
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Pharmacological ODC inhibition in rat hepatocyte culture. · source_derived_draft · unverified_draft
## agmatine-sulfate-depleted-polyamines A depleted downstream pool can change entry of another compound. Difluoromethylornithine-induced polyamine depletion increased agmatine uptake in cultured rat hepatocytes. Model: Pharmacological ODC inhibition in rat hepatocyte culture. Limitations: This is experimentally induced cellular polyamine depletion, not ordinary dietary agmatine deficiency. Evidence access: Primary abstract Transport and metabolism of agmatine in rat hepatocyte cultures. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11179960/ · DOI 10.1046/j.1432-1327.2001.01955.x
Complete structured claim and evidenceHuman GATM transferred the amidino group of arginine to beta-alanine, producing guanidinopropionate.
Experimental context and source evidence
- evidence_access
- Primary full text; Figure 4B
- experimental_model
- Recombinant human enzyme assay.
- limitations
- No competition magnitude with glycine or taurine in a living person was established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Beta-alanine connects to the guanidino-acid network through a distinct reaction.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 204–210
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human enzyme assay. · source_derived_draft · unverified_draft
## agmatine-sulfate-gatm-beta-alanine Beta-alanine connects to the guanidino-acid network through a distinct reaction. Human GATM transferred the amidino group of arginine to beta-alanine, producing guanidinopropionate. Model: Recombinant human enzyme assay. Limitations: No competition magnitude with glycine or taurine in a living person was established. Evidence access: Primary full text; Figure 4B Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceHuman GATM used GABA as an amidino acceptor to form guanidinobutyrate in vitro.
Experimental context and source evidence
- evidence_access
- Primary full text; Figure 4B
- experimental_model
- Purified human GATM.
- limitations
- Presence of this route does not prove a change in brain inhibitory neurotransmission after agmatine supplementation.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The same guanidino metabolite has another possible source besides agmatine oxidation.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 196–202
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human GATM. · source_derived_draft · unverified_draft
## agmatine-sulfate-gatm-gaba The same guanidino metabolite has another possible source besides agmatine oxidation. Human GATM used GABA as an amidino acceptor to form guanidinobutyrate in vitro. Model: Purified human GATM. Limitations: Presence of this route does not prove a change in brain inhibitory neurotransmission after agmatine supplementation. Evidence access: Primary full text; Figure 4B Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidencePurified human GATM transferred an amidino group from arginine to taurine, producing taurocyamine in vitro.
Experimental context and source evidence
- evidence_access
- Primary full text; Figure 4B
- experimental_model
- Recombinant human GATM substrate comparison.
- limitations
- Taurine is a secondary substrate in this assay; tissue flux and clinically important depletion were not established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Creatine-synthesis machinery also accepts a taurine-related side reaction.
- primary_references
- Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 188–194
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human GATM substrate comparison. · source_derived_draft · unverified_draft
## agmatine-sulfate-gatm-taurine Creatine-synthesis machinery also accepts a taurine-related side reaction. Purified human GATM transferred an amidino group from arginine to taurine, producing taurocyamine in vitro. Model: Recombinant human GATM substrate comparison. Limitations: Taurine is a secondary substrate in this assay; tissue flux and clinically important depletion were not established. Evidence access: Primary full text; Figure 4B Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
Complete structured claim and evidenceAgmatine entered rat liver mitochondrial matrix through membrane-potential-dependent transport; putrescine, arginine, ornithine and lysine did not inhibit uptake.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Isolated rat liver mitochondria; force-flux and inhibitor analysis.
- limitations
- The proposed transporter was not genetically identified; no single universal agmatine carrier is asserted.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Mitochondrial entry has different requirements from plasma-membrane entry.
- primary_references
- Agmatine is transported into liver mitochondria by a specific electrophoretic mechanism. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16509824/ · DOI 10.1042/BJ20060003
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 372–378
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Isolated rat liver mitochondria; force-flux and inhibitor analysis. · source_derived_draft · unverified_draft
## agmatine-sulfate-liver-mito-transport Mitochondrial entry has different requirements from plasma-membrane entry. Agmatine entered rat liver mitochondrial matrix through membrane-potential-dependent transport; putrescine, arginine, ornithine and lysine did not inhibit uptake. Model: Isolated rat liver mitochondria; force-flux and inhibitor analysis. Limitations: The proposed transporter was not genetically identified; no single universal agmatine carrier is asserted. Evidence access: Primary abstract Agmatine is transported into liver mitochondria by a specific electrophoretic mechanism. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16509824/ · DOI 10.1042/BJ20060003
Complete structured claim and evidenceAn inward proton gradient trans-stimulated efflux of intracellular agmatine from MATE1-expressing cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MATE1 expression; radiotracer efflux experiment.
- limitations
- This does not prescribe changing systemic pH.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The gradient helps determine transport direction.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 44–50
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MATE1 expression; radiotracer efflux experiment. · source_derived_draft · unverified_draft
## agmatine-sulfate-mate1-proton The gradient helps determine transport direction. An inward proton gradient trans-stimulated efflux of intracellular agmatine from MATE1-expressing cells. Model: Human MATE1 expression; radiotracer efflux experiment. Limitations: This does not prescribe changing systemic pH. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceMicrobial-community models predicted higher agmatine-production capacity in metformin-treated cohorts, including longitudinal treatment data.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_access
- Primary full text; Figure 5
- experimental_model
- Human microbiome composition and diet-constrained metabolic modeling.
- limitations
- Not a direct measurement of plasma agmatine or proof that agmatine causes metformin benefits in humans.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The human evidence here concerns a modeled capacity rather than a measured causal mediator.
- primary_references
- Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 420–426
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human microbiome composition and diet-constrained metabolic modeling. · source_derived_draft · unverified_draft
## agmatine-sulfate-microbiome-prediction The human evidence here concerns a modeled capacity rather than a measured causal mediator. Microbial-community models predicted higher agmatine-production capacity in metformin-treated cohorts, including longitudinal treatment data. Model: Human microbiome composition and diet-constrained metabolic modeling. Limitations: Not a direct measurement of plasma agmatine or proof that agmatine causes metformin benefits in humans. Evidence access: Primary full text; Figure 5 Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31474368/ · DOI 10.1016/j.cell.2019.08.003
Complete structured claim and evidenceA randomized trial of 2.670 g/day oral agmatine sulfate for 14 days reported greater pain and quality-of-life improvements than placebo; 51 and 48 were randomized, but 31 and 30 were analyzed.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Lumbar disc-associated radiculopathy; double-blind placebo-controlled trial after dose escalation.
- limitations
- Short exposure and reduced analyzed sample limit inference; molecular mediation and general chronic-pain efficacy were not established.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- There is limited human outcome evidence, with substantial attrition to consider.
- primary_references
- Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20447305/ · DOI 10.1111/j.1526-4637.2010.00808.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 436–442
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Lumbar disc-associated radiculopathy; double-blind placebo-controlled trial after dose escalation. · source_derived_draft · unverified_draft
## agmatine-sulfate-oral-clinical There is limited human outcome evidence, with substantial attrition to consider. A randomized trial of 2.670 g/day oral agmatine sulfate for 14 days reported greater pain and quality-of-life improvements than placebo; 51 and 48 were randomized, but 31 and 30 were analyzed. Model: Lumbar disc-associated radiculopathy; double-blind placebo-controlled trial after dose escalation. Limitations: Short exposure and reduced analyzed sample limit inference; molecular mediation and general chronic-pain efficacy were not established. Evidence access: Primary abstract Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20447305/ · DOI 10.1111/j.1526-4637.2010.00808.x
Complete structured claim and evidenceThree participants in the highest dose-escalation cohort reported diarrhea and mild nausea that resolved after stopping agmatine sulfate.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Open-label regimens from 1.335 to 3.560 g/day for 10–21 days preceding the randomized trial.
- limitations
- The source does not establish a safe maximum for all users or identify sulfate as the cause of the symptoms.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Tolerability at one dose and duration cannot establish universal long-term safety.
- primary_references
- Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20447305/ · DOI 10.1111/j.1526-4637.2010.00808.x
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 444–450
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Open-label regimens from 1.335 to 3.560 g/day for 10–21 days preceding the randomized trial. · source_derived_draft · unverified_draft
## agmatine-sulfate-oral-tolerability Tolerability at one dose and duration cannot establish universal long-term safety. Three participants in the highest dose-escalation cohort reported diarrhea and mild nausea that resolved after stopping agmatine sulfate. Model: Open-label regimens from 1.335 to 3.560 g/day for 10–21 days preceding the randomized trial. Limitations: The source does not establish a safe maximum for all users or identify sulfate as the cause of the symptoms. Evidence access: Primary abstract Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20447305/ · DOI 10.1111/j.1526-4637.2010.00808.x
Complete structured claim and evidencePolyamines inhibited MATE1-mediated agmatine transport, whereas L-arginine did not inhibit it in the tested system.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human MATE1-expressing HEK293 cells.
- limitations
- The primary abstract groups the polyamine competitors; no individual potency rank is assigned.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A shared precursor is not necessarily a transport competitor.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 52–58
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human MATE1-expressing HEK293 cells. · source_derived_draft · unverified_draft
## agmatine-sulfate-polyamine-competition A shared precursor is not necessarily a transport competitor. Polyamines inhibited MATE1-mediated agmatine transport, whereas L-arginine did not inhibit it in the tested system. Model: Human MATE1-expressing HEK293 cells. Limitations: The primary abstract groups the polyamine competitors; no individual potency rank is assigned. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceAgmatine lowered intracellular polyamines and suppressed transformed-cell proliferation; polyamine supplementation reversed growth suppression.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Transformed-cell supplementation experiment.
- limitations
- The accessed abstract reports polyamine supplementation as a group, not a spermidine-only rescue or cancer therapy.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Restoring a downstream pool changed the cellular outcome.
- primary_references
- Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9624108/ · DOI 10.1074/jbc.273.25.15313
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 348–354
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Transformed-cell supplementation experiment. · source_derived_draft · unverified_draft
## agmatine-sulfate-polyamine-rescue Restoring a downstream pool changed the cellular outcome. Agmatine lowered intracellular polyamines and suppressed transformed-cell proliferation; polyamine supplementation reversed growth suppression. Model: Transformed-cell supplementation experiment. Limitations: The accessed abstract reports polyamine supplementation as a group, not a spermidine-only rescue or cancer therapy. Evidence access: Primary abstract Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9624108/ · DOI 10.1074/jbc.273.25.15313
Complete structured claim and evidencePutrescine had little NMDA-blocking effect compared with agmatine or arcaine in the same experiments.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat neuron comparison of guanidine-containing and diamine compounds.
- limitations
- The result supports structural specificity; it does not measure metabolic conversion during recording.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Converting agmatine to a related amine can change channel activity.
- primary_references
- Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 276–282
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat neuron comparison of guanidine-containing and diamine compounds. · source_derived_draft · unverified_draft
## agmatine-sulfate-putrescine-nmda Converting agmatine to a related amine can change channel activity. Putrescine had little NMDA-blocking effect compared with agmatine or arcaine in the same experiments. Model: Rat neuron comparison of guanidine-containing and diamine compounds. Limitations: The result supports structural specificity; it does not measure metabolic conversion during recording. Evidence access: Primary abstract Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Complete structured claim and evidenceRat ALP catalytic activity required manganese; D217A and specified multi-residue substitutions abolished measured agmatinase activity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Recombinant rat protein, manganese activation and mutagenesis.
- limitations
- Mutations support residue importance but do not by themselves prove every proposed metal-coordination geometry.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- The metal-dependent catalytic machinery is a separate requirement from substrate supply.
- primary_references
- Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32531922/ · DOI 10.3390/ijms21114132
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 156–162
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant rat protein, manganese activation and mutagenesis. · source_derived_draft · unverified_draft
## agmatine-sulfate-rat-alp-metal The metal-dependent catalytic machinery is a separate requirement from substrate supply. Rat ALP catalytic activity required manganese; D217A and specified multi-residue substitutions abolished measured agmatinase activity. Model: Recombinant rat protein, manganese activation and mutagenesis. Limitations: Mutations support residue importance but do not by themselves prove every proposed metal-coordination geometry. Evidence access: Primary abstract Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32531922/ · DOI 10.3390/ijms21114132
Complete structured claim and evidenceSpermine still potentiated NMDA current in the presence of agmatine, supporting distinct interaction sites for the two compounds.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat hippocampal-neuron electrophysiology.
- limitations
- This is a cellular interaction, not evidence that co-supplementation is beneficial.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Two connected polyamine-related molecules can push the same channel in different directions.
- primary_references
- Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 268–274
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat hippocampal-neuron electrophysiology. · source_derived_draft · unverified_draft
## agmatine-sulfate-spermine-nmda Two connected polyamine-related molecules can push the same channel in different directions. Spermine still potentiated NMDA current in the presence of agmatine, supporting distinct interaction sites for the two compounds. Model: Rat hippocampal-neuron electrophysiology. Limitations: This is a cellular interaction, not evidence that co-supplementation is beneficial. Evidence access: Primary abstract Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. · 1999 · https://pubmed.ncbi.nlm.nih.gov/9918557/
Complete structured claim and evidenceHuman AGMAT expression supported growth of polyamine-biosynthesis-deficient yeast in the presence of agmatine despite absent directly measured in vitro agmatinase activity.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Saccharomyces cerevisiae TRY104Δspe1 complementation plus enzyme assays.
- limitations
- Indirect yeast rescue is retained as reported; it is not sufficient to override later direct human substrate-specificity experiments.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- Growth complementation and direct enzyme catalysis answer different questions.
- primary_references
- Mammalian agmatinases constitute unusual members in the family of Mn2+-dependent ureahydrolases. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27846445/ · DOI 10.1016/j.jinorgbio.2016.11.015
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 164–170
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Saccharomyces cerevisiae TRY104Δspe1 complementation plus enzyme assays. · source_derived_draft · unverified_draft
## agmatine-sulfate-yeast-rescue Growth complementation and direct enzyme catalysis answer different questions. Human AGMAT expression supported growth of polyamine-biosynthesis-deficient yeast in the presence of agmatine despite absent directly measured in vitro agmatinase activity. Model: Saccharomyces cerevisiae TRY104Δspe1 complementation plus enzyme assays. Limitations: Indirect yeast rescue is retained as reported; it is not sufficient to override later direct human substrate-specificity experiments. Evidence access: Primary abstract Mammalian agmatinases constitute unusual members in the family of Mn2+-dependent ureahydrolases. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27846445/ · DOI 10.1016/j.jinorgbio.2016.11.015
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.